Compounds > 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
Page last updated: 2024-09-03

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and n-methylcytisine

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with n-methylcytisine in 1 studies

Compound Research Comparison

Studies
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Trials
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Recent Studies (post-2010)
(3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole)		Studies
(n-methylcytisine)		Trials
(n-methylcytisine)		Recent Studies (post-2010) (n-methylcytisine)
6821821010

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bottlaender, M; Crouzel, C; Dolci, L; Dollé, F; Syrota, A; Valette, H1

Other Studies

1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and n-methylcytisine

ArticleYear
An attempt to visualize baboon brain nicotinic receptors with N-[11C]ABT-418 and N-[11C]methyl-cytisine.
    Nuclear medicine communications, 1997, Volume: 18, Issue:2

    Topics: Alkaloids; Animals; Anti-Anxiety Agents; Carbon Radioisotopes; Cerebral Cortex; Isoxazoles; Kinetics; Papio; Pyrrolidines; Quinolizines; Receptors, Nicotinic; Tomography, Emission-Computed

1997